Searchable abstracts of presentations at key conferences in endocrinology

ea0050p397 | Thyroid | SFEBES2017

Primary versus tertiary care follow-up of low risk well differentiated thyroid cancer

Imran Syed , Rajaraman Mal , Chu Karen , VanUum Stan , Kaiser Stephanie

The optimum approach to long-term follow-up of well differentiated thyroid cancer (DTC) remains unclear. We assessed the outcome of DTC patients followed in primary care (PrC) from Edmonton, AB with tertiary care (TrC) settings from Halifax, NS and London, ON. Patients who met the following criteria were identified: a) Initial diagnosis between January 1, 2006 to December 31, 2011, b) primary tumourA total of 317 patients, (PrC=93 and TrC=2...

ea0050p397 | Thyroid | SFEBES2017

Primary versus tertiary care follow-up of low risk well differentiated thyroid cancer

Imran Syed , Rajaraman Mal , Chu Karen , VanUum Stan , Kaiser Stephanie

The optimum approach to long-term follow-up of well differentiated thyroid cancer (DTC) remains unclear. We assessed the outcome of DTC patients followed in primary care (PrC) from Edmonton, AB with tertiary care (TrC) settings from Halifax, NS and London, ON. Patients who met the following criteria were identified: a) Initial diagnosis between January 1, 2006 to December 31, 2011, b) primary tumourA total of 317 patients, (PrC=93 and TrC=2...

ea0065p277 | Neuroendocrinology | SFEBES2019

Secondary hormonal deficiency patterns vary among different types of sellar masses despite similar size at presentation

Kaiser Stephanie M , Almistehi Wael , Hebb Andrea , Clarke David B , Ali Imran Syed

Secondary hormonal deficiency (SHD) in sellar masses (SM) is thought to be partly due to compression of the portal vessels by the enlarging tumour restricting the blood supply to the normal pituitary tissue. However, to date no study has looked at the patterns of SHD in various types of SM and assessed if SHD is related solely to the size of SM or is associated with the underlying pathology. We assessed 914 patients with SM enrolled in our comprehensive pituitary registry sinc...

ea0044p17 | Adrenal and Steroids | SFEBES2016

The effect of time of day and utility of 30 and 60 min values in 250 μg ACTH stimulation test

Munro Vicki , Elnenaei Manal , Doucette Steve , Kaiser Stephanie , Ali Imran Syed

Background: Despite the widespread use of the 250-μg Cosyntropin test (ACTH test) for the diagnosis of adrenal insufficiency (AI), the effect of timing of the test on 30- vs. 60-min serum cortisol values remains unclear. Also, there is limited evidence comparing the value of performing both 30- and 60-min cortisol levels.Methods: We conducted a retrospective cohort study of all ACTH tests conducted at the Halifax Neuropituitary Program, Nova Scotia,...

ea0038p303 | Pituitary | SFEBES2015

An association between visual morphometric changes and psychiatric outcomes in patients with acromegaly

Imran Syed , Vallis Michael , Tiemesma Jitske , Siddiqi Ferhan , Yip Churn-Ern , Tugwell Barna , Ransom Thomas , Tramble Lisa , Abidi Ebad , Clarke David , Kaiser Stephanie

Background: Acromegaly (Acro) is associated with adverse psychopathological and personality outcomes despite being in remission for over a decade. We hypothesised that persistently poor psychological outcomes may be associated with morphometric changes experienced by Acro patients.Methodology: We compared 60 consecutive non-functioning adenoma (NFA) and Acro patients who had undergone pituitary surgery and/or radiation therapy (RT). A gender-specific vis...

ea0038p318 | Pituitary | SFEBES2015

An association between self-drawing, morphometric changes and psychological outcomes in patients with acromegaly vs non-functioning pituitary adenoma

Kaiser Stephanie , Tiemensema Jitske , Vallis Michael , Siddiqi Ferhan , Yip Churn-Ern , Tugwell Barna , Ransom Thomas , Tramble Lisa , Abidi Ebad , Clarke David , Imran Syed Ali

We recently developed a visual scale to assess the extent of morphometric changes in Acromegaly (Acro) patients which is strongly predictive of adverse psychological outcomes. We sought to identify if there was any association between the self-drawing test and the visual morphometric scale and if there was any correlation with psychological outcomes.We compared 60 consecutive non-functioning adenoma (NFA) and Acro patients who had undergone pituitary sur...

ea0090p29 | Calcium and Bone | ECE2023

TransCon PTH Improves Health-Related Quality of Life and Reduces Work Limitations in Adults With Hypoparathyroidism: Patient-Reported Outcomes in the Phase 3 PaTHway Trial

Palermo Andrea , Khan Aliya , Rubin Mishaela , Schwarz Peter , Shoback Dolores M. , Gagnon Claudia , Cetani Filomena , Clarke Bart L. , Tsourdi Elena , Kohlmeier Lynn , Sikjaer Tanja , M Kaiser Stephanie , Lai Bryant , Le John , Ukena Jenny , Sibley Christopher , Shu Aimee , An Xubei , Noori Wahidullah , Smith Alden , Vokes Tamara J.

Background: Individuals with hypoparathyroidism often experience a range of symptoms associated with reduced health-related quality of life (HRQoL) and work productivity. Conventional therapy aims to alleviate hypocalcemia and acute symptoms but fails to restore normal parathyroid hormone (PTH) physiology or improve HRQoL. In the PaTHway trial, 79% of participants treated with TransCon PTH vs. 5% placebo (P<0.0001) met the primary efficacy endpoint (normal serum c...